The study, which showed that hydrocelin is non-pyrogenic, was part of a series of preclinical tests into several safety aspects for the product, all of which have yielded a satisfactory profile.

a biomedical company developing transformative nanotechnology-based treatments for degenerative joint disease, today presented positive preclinical data demonstrating the satisfactory safety profile ...

The drilling and subsequent resource estimates and engineering studies led to a revised MRE and an updated PEA being published and filed in August of 2024, which studies are available at the Company's ...

In the world of electric vehicles, there’s a Chinese company outdoing Elon Musk’s Tesla. And it’s just getting started. BYD, the Shenzhen-based Chinese EV champion, eclipsed Tesla in annual ...

Financial statements are reports compiled by businesses that detail the company's financial activities and health. Financial statements are often audited by government agencies and accountants to ...

Petosemtamab in combination with pembrolizumab in 1L PD-L1+ r/m HNSCC interim clinical data selected for poster presentation - Conference call on Thursday, May 22 at 5:30 p.m. ET to discuss full ...